Daniel O'Connor is the consultant principal and major shareholder of Xenex Consulting and the Keys2Growth program. He has assisted companies in expanding their international trading boundaries by a disciplined process of planning, funding, and implementing key strategic business initiatives thereby adding value to all stakeholders.
| Rank | Company | # | |
|---|---|---|---|
| 90th | - | Volt Group | $5.90m |
| 91st | - | Botanix Pharmaceuticals | $5.79m |
| 92nd | - | Holista CollTech | $5.66m |
| 93rd | - | Artrya | $5.49m |
|
REMUNERATION UPDATE: Non-Executive Director, Holista CollTech | 24 Aug 2020 |
|
|
REMUNERATION UPDATE: Non-Executive Director, Holista CollTech | 30 Jun 2020 |
| Position | Company | Year | Company's current rank |
|---|---|---|---|
Non-Executive Director
|
2011 - 2021 | 92 |
| Company | Date | Transaction type | Number of shares | Price per share | Transaction value | Nature of change |
|---|---|---|---|---|---|---|
| 2020-08-31 | Issued | 3,500,000 | $0.00 | Other |
